These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 2584393)
1. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393 [TBL] [Abstract][Full Text] [Related]
2. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
3. Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome. Jauberteau MO; Gualde N; Preud'Homme JL; Rigaud M; Gil R; Vallat JM; Baumann N Clin Exp Immunol; 1990 May; 80(2):186-91. PubMed ID: 2357844 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy. Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. Ilyas AA; Willison HJ; Dalakas MC; Whitaker JN; Quarles RH J Neurochem; 1988 Sep; 51(3):851-8. PubMed ID: 2457654 [TBL] [Abstract][Full Text] [Related]
6. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome. Neisser A; Schwerer B; Bernheimer H; Moran AP J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671 [TBL] [Abstract][Full Text] [Related]
7. The spectrum of neurologic disease associated with anti-GM1 antibodies. Sadiq SA; Thomas FP; Kilidireas K; Protopsaltis S; Hays AP; Lee KW; Romas SN; Kumar N; van den Berg L; Santoro M Neurology; 1990 Jul; 40(7):1067-72. PubMed ID: 2162499 [TBL] [Abstract][Full Text] [Related]
8. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Nardelli E; Steck AJ; Barkas T; Schluep M; Jerusalem F Ann Neurol; 1988 May; 23(5):524-8. PubMed ID: 3389760 [TBL] [Abstract][Full Text] [Related]
9. IgG antibody against GM1, GD1b and asialo-GM1 in chronic polyneuropathy following Mycoplasma pneumoniae infection. Yoshino H; Inuzuka T; Miyatake T Eur Neurol; 1992; 32(1):28-31. PubMed ID: 1563451 [TBL] [Abstract][Full Text] [Related]
10. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy. Shy ME; Heiman-Patterson T; Parry GJ; Tahmoush A; Evans VA; Schick PK Neurology; 1990 May; 40(5):842-4. PubMed ID: 2330115 [TBL] [Abstract][Full Text] [Related]
11. Preparation and properties of antibodies to GD3 and GM1 gangliosides. Kundu SK; Marcus DM; Veh RW J Neurochem; 1980 Jan; 34(1):184-8. PubMed ID: 6778957 [TBL] [Abstract][Full Text] [Related]
12. Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome. Koga M; Tatsumoto M; Yuki N; Hirata K J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):123-4. PubMed ID: 11413278 [TBL] [Abstract][Full Text] [Related]
13. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1. Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647 [TBL] [Abstract][Full Text] [Related]
14. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome. Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Gregson NA; Koblar S; Hughes RA Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986 [TBL] [Abstract][Full Text] [Related]
16. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790 [TBL] [Abstract][Full Text] [Related]
17. IgG anti-ganglioside antibodies and their subclass distribution in two patients with acute and chronic motor neuropathy. Garcia Guijo C; Garcia-Merino A; Rubio G; Guerrero A; Cruz Martinez A; Arpa J J Neuroimmunol; 1992 Mar; 37(1-2):141-8. PubMed ID: 1372326 [TBL] [Abstract][Full Text] [Related]
18. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy. Yoshino H; Miyatani N; Saito M; Ariga T; Lugaresi A; Latov N; Kushi Y; Kasama T; Yu RK J Neurochem; 1992 Nov; 59(5):1684-91. PubMed ID: 1383424 [TBL] [Abstract][Full Text] [Related]
19. A novel ganglioside, 9-O-acetyl GD1b, is recognized by serum antibodies in Guillain-Barré syndrome. Hitoshi S; Kusunoki S; Kon K; Chiba A; Waki H; Ando S; Kanazawa I J Neuroimmunol; 1996 May; 66(1-2):95-101. PubMed ID: 8964919 [TBL] [Abstract][Full Text] [Related]
20. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy. Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]